Stefania Di Marco, Ph.D., Qualified Person of ADVENT, and Daniel Conlon, IRBM’s VP of Business Development, North America, will be attending the World Vaccine Congress in Washington, D.C. from April 14 to April 17. To learn more about ADVENT’s capabilities, and how this cGMP CMO facility can support your vaccine development and manufacturing, feel free to contact us to organize a meeting.